Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston Linehan

Showing results (441-450 of 487) with videos related to

Pageof 49
Sort By:
Neoplasia (New York, N.Y.)|April 5, 2013
Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomasUma Shankavaram, Stephanie M J Fliedner, Abdel G Elkahloun, et al.
The Journal of Urology|September 17, 2004
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogeneLaura S Schmidt, Michael L Nickerson, Debora Angeloni, et al.
Cell Chemical Biology|February 7, 2017
Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity ProfilingRhushikesh A Kulkarni, Andrew J Worth, Thomas T Zengeya, et al.
EMBO Molecular Medicine|March 29, 2023
TFEB and TFE3 drive kidney cystogenesis and tumorigenesisChiara Di Malta, Angela Zampelli, Letizia Granieri, et al.
JAMA Dermatology|May 27, 2026
Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained IndividualsAlisa M Goldstein, Jung Kim, Jeremy S Haley, et al.
Oncotarget|May 3, 2018
ONC201 kills breast cancer cells <i>in vitro</i> by targeting mitochondriaYoshimi Endo Greer, Natalie Porat-Shliom, Kunio Nagashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge ConferenceMichael B Atkins, Marc S Ernstoff, Robert A Figlin, et al.
Plos Genetics|October 25, 2011
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factorsLee E Moore, Michael L Nickerson, Paul Brennan, et al.
Human Molecular Genetics|December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferationHisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Oncotarget|January 24, 2022
Seventh BHD international symposium: recent scientific and clinical advancementMark R Woodford, Avgi Andreou, Masaya Baba, et al.
Pageof 49

Showing results (441-450 of 487) with videos related to

Sort By:
Pageof 49
Neoplasia (New York, N.Y.)|April 5, 2013
Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomasUma Shankavaram, Stephanie M J Fliedner, Abdel G Elkahloun, et al.
The Journal of Urology|September 17, 2004
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogeneLaura S Schmidt, Michael L Nickerson, Debora Angeloni, et al.
Cell Chemical Biology|February 7, 2017
Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity ProfilingRhushikesh A Kulkarni, Andrew J Worth, Thomas T Zengeya, et al.
EMBO Molecular Medicine|March 29, 2023
TFEB and TFE3 drive kidney cystogenesis and tumorigenesisChiara Di Malta, Angela Zampelli, Letizia Granieri, et al.
JAMA Dermatology|May 27, 2026
Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained IndividualsAlisa M Goldstein, Jung Kim, Jeremy S Haley, et al.
Oncotarget|May 3, 2018
ONC201 kills breast cancer cells <i>in vitro</i> by targeting mitochondriaYoshimi Endo Greer, Natalie Porat-Shliom, Kunio Nagashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge ConferenceMichael B Atkins, Marc S Ernstoff, Robert A Figlin, et al.
Plos Genetics|October 25, 2011
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factorsLee E Moore, Michael L Nickerson, Paul Brennan, et al.
Human Molecular Genetics|December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferationHisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Oncotarget|January 24, 2022
Seventh BHD international symposium: recent scientific and clinical advancementMark R Woodford, Avgi Andreou, Masaya Baba, et al.
Pageof 49